PCLX-001 - CAS 1215011-08-7

PCLX-001 is a small-molecule compound that acts as an orally active inhibitor of N-myristoyltransferase (NMT), specifically targeting NMT1 and NMT2 with IC50 values of 5 nM and 8 nM, respectively. This compound demonstrates anti-tumor effects and effectively inhibits the early signaling of B-cell receptor (BCR) . Consequently, PCLX-001 is a valuable tool for researching B-cell malignancies [1] [2].

Others

Others

1215011-08-7

0.996

C24H30Cl2N6O2S

537.51

N(S(=O)(=O)C1=C(Cl)C=C(C=C1Cl)C=2C=C(N=CC2)N3CCNCC3)C=4C(CC(C)C)=NN(C)C4C

-20°C

Ice Packs

Small Compound